Moreover, Th17 numbers were increased in MDS patients, with greater expansion in low-risk disease, denoting the auto-reactive, possible anti-tumor nature of the process [82,83], whereas Th22 cells were increased in high-risk disease, correlating with increased IL-6 and TNF-a [82]. Here, IL6 is linked to myelodysplastic syndrome.